FDA Approves New Targeted Pill for Advanced Pancreatic Cancer, Offering Patients a New Treatment Option
WASHINGTON, D.C. — A significant development in pancreatic cancer treatment has emerged in the United States after the U.S. Food...
FDA Approval
FDA Approves New Targeted Drug Showing Major Survival Benefit in Advanced Pancreatic Cancer
August 27, 2026 The U.S. Food and Drug Administration has approved Rasonque (daraxonrasib), a new targeted medicine developed by Revolution...
FDA Approves Lipfendra, the First Once-Daily Oral PCSK9 Inhibitor for Lowering LDL Cholesterol
The U.S. Food and Drug Administration (FDA) has approved Lipfendra (enlicitide), a once-daily oral medication designed to help adults lower...
